Mark Stow
Impact in
-
- Transgenic Plants and Applications
-
- Protease and Inhibitor Mechanisms
Papers in
-
- Bone Metabolism and Diseases 2
- Metabolism, Diabetes, and Cancer 1
- Peroxisome Proliferator-Activated Receptors 1
- Oncology 3
- Bone health and treatments 2
- Co-authors
- Adrienne M. Flanagan (2 shared papers)Jessica A. Chichester (1 shared paper)Vidadi Yusibov (1 shared paper)Brian J. Green (1 shared paper)George I. Moonsammy (1 shared paper)Stephen J. Streatfield (1 shared paper)R. Mark Jones (1 shared paper)Richard Williams (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (1 paper)Viruses (1 paper)Clinical & Experimental Immunology (1 paper)The Journal of Steroid Biochemistry and Molecular Biology (1 paper)The Journal of Pathology (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Stow
8 papers receiving 152 citations
Peers
Comparison fields: 5 of 52
- Biotechnology 46
- Cancer Research 37
- Hematology 16
- Oncology 37
- Immunology 28
Countries citing papers authored by Mark Stow
This map shows the geographic impact of Mark Stow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stow more than expected).
Fields of papers citing papers by Mark Stow
This network shows the impact of papers produced by Mark Stow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stow. The network helps show where Mark Stow may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Stow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 55 | |
| 2 | 2000 | 28 | |
| 3 | 2002 | 20 | |
| 4 | 1995 | 15 | |
| 5 | The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro. | 1995 | 13 |
| 6 | 1993 | 13 | |
| 7 | 2003 | 12 | |
| 8 | 2001 | 9 |
About Mark Stow
Mark Stow is a scholar working on Molecular Biology, Oncology, Hematology, Cancer Research and Infectious Diseases, having authored 8 papers that have together received 165 indexed citations. Recurring topics across this work include Bone health and treatments (2 papers), Bone Metabolism and Diseases (2 papers), Metabolism, Diabetes, and Cancer (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Blood groups and transfusion (1 paper), Skin and Cellular Biology Research (1 paper), Protease and Inhibitor Mechanisms (1 paper) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Biotechnology (46 citations), Cancer Research (37 citations), Hematology (16 citations), Oncology (37 citations) and Immunology (28 citations). Mark Stow has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Adrienne M. Flanagan, Jessica A. Chichester, Vidadi Yusibov, Brian J. Green, George I. Moonsammy, Stephen J. Streatfield, R. Mark Jones, Richard Williams, Ashfaq A. Parkar and R A Jupp. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Viruses, Clinical & Experimental Immunology, The Journal of Steroid Biochemistry and Molecular Biology and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.